EarningsQ4 2024 Earnings Report

Teva Pharmaceutical (TEVAN) Q4 2024 Earnings Report

0 Followers

MX:TEVAN Q4 2024 EPS Results

Actual EPS$12.23

Consensus EPS$12.17

Beat/MissBeat by +$0.05

One Year Ago EPS$17.22

Actual Revenue$72.83B

Expected Revenue$71.39B

Beat/MissBeat by +$1.44B

YoY Revenue Growth-6.58%

QuarterQ4 2024

Date01/29/2025

TimeBefore Open

Conference CallWednesday, January 29, 2025

MX:TEVAN Upcoming Earnings

Teva Pharmaceutical's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:TEVAN Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	12.00 / -	13.431	―
Jul 29, 2026	2026 (Q2)	0.90 / 0.34	11.365	-96.97% (-11.02)
Apr 29, 2026	2026 (Q1)	8.11 / 9.13	8.954	1.92% (+0.17)
Jan 28, 2026	2025 (Q4)	11.04 / 16.53	12.226	35.21% (+4.30)
Nov 05, 2025	2025 (Q3)	11.88 / 13.43	11.881	13.04% (+1.55)
Jul 30, 2025	2025 (Q2)	10.62 / 11.36	10.504	8.20% (+0.86)
May 07, 2025	2025 (Q1)	7.96 / 8.95	8.265	8.33% (+0.69)
Jan 29, 2025	2024 (Q4)	12.17 / 12.23	17.219	-29.00% (-4.99)
Nov 06, 2024	2024 (Q3)	11.38 / 11.88	10.332	15.00% (+1.55)
Jul 31, 2024	2024 (Q2)	9.51 / 10.50	9.643	8.93% (+0.86)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed